SynthesisMedicine2018

S-1 plus cisplatin with concurrent radiotherapy for stage III non-small cell lung cancer: A meta-analysis (PRISMA) of randomized control trials.

Shuai Qie et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.